Crafted with care. Rooted in royalty. 👸🏾💛
The newest drop from @houseofsheba_ is here!

Now available to order 😊 but don’t wait, we’re selling fast!
✨ Summa is here and so is your next statement dress 🤭✍️❗️

📲 DM us or contact us directly:
🇺🇸 +1 (202) 913-7837
🇪🇹 +251 92 911 1644

Follow us on Instagram & TikTok for more!

MELKAM YE FASIKA BEAL YADEREGELEN
🙏🏾🙏🏾🙏🏾

It’s not me it’s the dress💚👑 @mebaeta_

Contacts us: +1 (202) 913-7837 / +251 92 911 1644

President Trump announced plans to sign an executive order aimed at reducing U.S. drug prices by implementing a "Most Favored Nation" (MFN) policy. This policy would direct the Department of Health and Human Services to negotiate lower drug prices with pharmaceutical companies, tying U.S. prices to the lowest prices paid by other countries. ⁠
⁠
The order is set to focus on Medicare Part B drugs, which include medications administered in a doctor's office, such as cancer treatments. Trump claims the policy could reduce costs by 30% to 80% and save the U.S. "TRILLIONS OF DOLLARS."⁠
⁠
This latest order is a continuation of Trump's efforts from his first term to address the high cost of U.S. drugs via price controls. In 2020, he signed a similar executive order aimed at tying U.S. drug prices to international benchmarks, but the proposal faced significant opposition from the pharmaceutical industry. Critics argued that such a policy would harm innovation and reduce access to new medications. Trump's 2020 attempt was blocked by a federal court after he left office, preventing its implementation under President Biden. ⁠
⁠
The MFN policy is likely to face similar resistance from the pharmaceutical industry, which argues that forcing lower prices could stifle innovation, leading to fewer new medicines and potentially harming the U.S.'s role as a global leader in drug development. ⁠
⁠
Pharmaceutical companies contend that the policy would grant foreign governments excessive influence over U.S. drug pricing, undermining the ability of the U.S. market to set fair and competitive prices. Despite this opposition, the proposal reflects ongoing frustrations with U.S. drug pricing, a long-standing issue that has drawn bipartisan criticism.⁠
⁠
Head to the link in bio for the full story

FULL LIST: Nigeria’s varsities that accept 140, 150, 160 JAMB scores for admission

Following the low pass rate recorded in the 2025 Unified Tertiary Matriculation Examination (UTME) conducted by the Joint Admissions and Matriculation Board (JAMB), many students across the country have been left anxious and uncertain about their next steps. The disappointing results have sparked widespread concern, especially among candidates who had high hopes of gaining admission into top-tier institutions. With cut-off marks likely to be affected and competition for available slots even tighter, students are now reassessing their options and exploring alternative institutions and courses they might not have initially considered.

As the admission season approaches, questions about school choices, catchment areas, and departmental requirements have become top of mind for students and parents alike. Many are turning to educational consultants, online forums, and career guidance counselors in search of reliable advice. For some, the focus has shifted from prestigious universities to more accessible polytechnics and colleges of education, while others are considering taking a gap year to prepare for the next UTME cycle. The uncertainty has created a sense of urgency, as students scramble to secure a spot in any institution that matches their scores and career aspirations.

Please click the link in bio to read more